ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT and MVR-T3011 IV in both U.S. and China with all selected to be published at the 2023 American Society for Clinical Oncology Annual Meeting taking place from June 2nd to 6th, 2023 in Chicago, IL.
